- Oxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
-
Kang SH, Kim JI, Moon HS, Kim SH, Sung JK, Lee BS, Jeong HY
- KMID: 1775923
- Korean J Gastroenterol.
- 2010 Jan;55(1):26-32.
- doi: 10.4166/kjg.2010.55.1.26
BACKGROUND/AIMS: We performed retrospective study in order to compare oxaliplatin, leucovorin, and fluorouracil (FOLFOX) versus irinotecan, leucovorin, and fluorouracil (FOLFIRI) in recurred or metastatic gastric adenocarcinoma. METHODS: We investigated 56 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
-
Hwang J, Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ
- KMID: 1785814
- J Korean Med Sci.
- 2008 Aug;23(4):586-591.
- doi: 10.3346/jkms.2008.23.4.586
This phase II study evaluated the efficacy and safety of combination chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were eligible... -
- CITED
-
- Close
- SHARE
-
- Close
- Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
-
Jeong JH, Cho BC, Shim HS, Kim HR, Lim SM, Kim SK, Chung KY, Islam SM, Song JJ, Kim SY, Kim JH
- KMID: 1777495
- J Korean Med Sci.
- 2013 Jul;28(7):1005-1014.
- doi: 10.3346/jkms.2013.28.7.1005
Transglutaminase 2 (TG2), a cross-linking enzyme, is involved in drug resistance and in the constitutive activation of nuclear factor kappa B (NF-kappaB). We investigated the association of non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
